Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1
- PMID: 1730726
Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1
Abstract
Three ribozymes targeted against different sites of the long terminal repeat RNA (LTR RNA) of human immunodeficiency virus type 1 cleaved a LTR RNA transcript 1,000 x less efficiently than corresponding short synthetic oligoribonucleotide substrates. Varying the stem lengths of the ribozyme resulted in changes of the catalytic efficiency. Almost no cleavage was observed for a ribozyme forming only 10 base pairs instead of 14 with the LTR RNA. Increasing the base pairs to 16 or elongation of the stem formed within the ribozyme revealed only small changes in kcat/Km. The influence of chemical modifications within the ribozyme on the cleavage of the LTR RNA was also examined. 2'-Fluorocytidine substitutions as well as four terminal phosphorothioate internucleotidic linkages influenced the catalytic efficiency of ribozymes only negligibly. However, substitution of uridine by 2'-fluorouridine resulted in a 5-fold decrease of kcat/Km. A ribozyme containing all these modifications revealed only a 7-fold lower catalytic efficiency but a markedly increased stability in cell culture supernatant. These results demonstrate that it is possible to increase the stability of ribozymes toward nucleases without a serious loss in catalytic efficiency.
Similar articles
-
HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.Nucleic Acids Res. 2000 Nov 1;28(21):4059-67. doi: 10.1093/nar/28.21.4059. Nucleic Acids Res. 2000. PMID: 11058100 Free PMC article.
-
High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates.J Biol Chem. 1994 Jan 21;269(3):2131-8. J Biol Chem. 1994. PMID: 8294467
-
The effect of structure in a long target RNA on ribozyme cleavage efficiency.Nucleic Acids Res. 1997 Dec 15;25(24):4985-93. doi: 10.1093/nar/25.24.4985. Nucleic Acids Res. 1997. PMID: 9396806 Free PMC article.
-
Inhibition of gene expression with ribozymes.Cell Mol Neurobiol. 1994 Oct;14(5):523-38. doi: 10.1007/BF02088835. Cell Mol Neurobiol. 1994. PMID: 7621511 Free PMC article. Review.
-
Anti-HIV ribozymes.Mol Biotechnol. 1997 Jun;7(3):241-51. doi: 10.1007/BF02740815. Mol Biotechnol. 1997. PMID: 9219238 Review.
Cited by
-
Peptide nucleic acid (PNA) is capable of enhancing hammerhead ribozyme activity with long but not with short RNA substrates.Nucleic Acids Res. 1997 Jul 15;25(14):2690-3. doi: 10.1093/nar/25.14.2690. Nucleic Acids Res. 1997. PMID: 9207013 Free PMC article.
-
Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.Nucleic Acids Res. 1994 Sep 25;22(19):3951-7. doi: 10.1093/nar/22.19.3951. Nucleic Acids Res. 1994. PMID: 7524030 Free PMC article.
-
Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.Pharm Res. 1995 Apr;12(4):465-83. doi: 10.1023/a:1016281324761. Pharm Res. 1995. PMID: 7596980 Review.
-
Ribozymes: biology, biochemistry, and implications for clinical medicine.J Mol Med (Berl). 1995 Feb;73(2):65-71. doi: 10.1007/BF00270579. J Mol Med (Berl). 1995. PMID: 7627631 Review.
-
HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.Nucleic Acids Res. 2000 Nov 1;28(21):4059-67. doi: 10.1093/nar/28.21.4059. Nucleic Acids Res. 2000. PMID: 11058100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources